Cell Source (CLCS) Financial Statements
Cell Source Financial Overview
Cell Source's market cap is currently $36.49M. The company's EPS TTM is $-0.15; its P/E ratio is -5.30; Cell Source has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Operating Income | $ -2.73M | $ -3.85M | $ -4.33M | $ -4.17M | $ -4.02M |
| EBITDA | $ -2.73M | $ -3.60M | $ -3.89M | $ 333.00 | $ -93.43K |
| Net Income | $ -4.64M | $ -4.77M | $ -5.32M | $ -5.17M | $ -5.47M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 461.86K | $ 74.63K | $ 22.20K | $ 222.66K | $ 93.09K |
| Total Assets | $ 464.11K | $ 286.50K | $ 195.17K | $ 409.85K | $ 313.77K |
| Total Debt | $ 12.98M | $ 10.07M | $ 9.25M | $ 7.90M | $ 6.47M |
| Net Debt | $ 12.52M | $ 9.99M | $ 9.23M | $ 7.68M | $ 6.38M |
| Total Liabilities | $ 22.93M | $ 19.08M | $ 15.81M | $ 13.04M | $ 10.14M |
| Stockholders' Equity | $ -22.46M | $ -18.80M | $ -15.61M | $ -12.63M | $ -9.83M |
| Cash Flow | |||||
| Free Cash Flow | $ -2.73M | $ -2.68M | $ -2.35M | $ -3.14M | $ -3.38M |
| Operating Cash Flow | $ -2.73M | $ -2.68M | $ -2.35M | $ -3.14M | $ -3.38M |
| Investing Cash Flow | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Financing Cash Flow | $ 3.12M | $ 2.74M | $ 2.15M | $ 3.27M | $ 3.23M |
Currency in USD
